New York-based Healthee, a healthcare advantages navigation platform, introduced an oversubscribed $50 million Sequence B funding increase led by Key1 Capital.
Present buyers Group11, Fin Capital and Glilot Capital Companions additionally participated within the spherical.
The corporate mentioned in an announcement that it didn’t formally launch the increase however moderately was approached by the spherical’s lead investor after monitoring the corporate’s progress.
WHAT IT DOES
Healthee affords a platform that solutions staff’ questions concerning advantages, protection and remedy. It additionally gives open enrollment help and preventative care suggestions.
The corporate will use the funds to broaden its choices and scale its operations.
“The truth that this spherical got here collectively with out us actively searching for it speaks volumes,” Man Benjamin, CEO and cofounder of Healthee, mentioned in an announcement.
“Our buyers see what we see: an enormous alternative to vary how staff expertise healthcare and the way employers ship it. This funding provides us the assets to speed up that mission and proceed delivering a greater, smarter option to navigate advantages.”
MARKET SNAPSHOT
Final 12 months, Healthee scored $32 million in a Sequence A funding spherical.
The corporate launched in 2021 as Insurights, at which period it raised $22 million in seed funding. It was rebranded to Healthee in 2022.
In 2023, Healthee introduced a collaboration with human assets firm TriNet to offer its clients with entry to Healthee’s advantages navigation choices, together with people who assist staff select the best healthcare advantages and navigate present advantages.
Different firms providing healthcare advantages navigation embrace Solace, which secured $60 million in Sequence B funding this month, lower than one 12 months after scoring $14 million in Sequence A funding.
Sharecare additionally affords a digital healthcare navigation platform for people, employers, authorities organizations, communities, well being plans and suppliers.
The as soon as publicly traded firm was acquired by funding agency Altaris in 2024 in a $518 million deal that noticed Sharecare go non-public.
Different firms within the area embrace Glen Tullman’s firm Transcarent, Rightway and Pebble.
